JP2022514148A5 - - Google Patents
Info
- Publication number
- JP2022514148A5 JP2022514148A5 JP2021518202A JP2021518202A JP2022514148A5 JP 2022514148 A5 JP2022514148 A5 JP 2022514148A5 JP 2021518202 A JP2021518202 A JP 2021518202A JP 2021518202 A JP2021518202 A JP 2021518202A JP 2022514148 A5 JP2022514148 A5 JP 2022514148A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- bispecific binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862740337P | 2018-10-02 | 2018-10-02 | |
| US62/740,337 | 2018-10-02 | ||
| PCT/JP2019/038750 WO2020071365A1 (en) | 2018-10-02 | 2019-10-01 | Bi-specific binding agents targeting syndecan-1 and fibroblast growth factor receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514148A JP2022514148A (ja) | 2022-02-10 |
| JP2022514148A5 true JP2022514148A5 (https=) | 2022-07-28 |
Family
ID=70055592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518202A Withdrawn JP2022514148A (ja) | 2018-10-02 | 2019-10-01 | シンデカン－１および線維芽細胞増殖因子受容体を標的とする二重特異性結合物質 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220249679A1 (https=) |
| EP (1) | EP3861117A4 (https=) |
| JP (1) | JP2022514148A (https=) |
| KR (1) | KR20210070307A (https=) |
| CN (1) | CN113039271A (https=) |
| AR (1) | AR116563A1 (https=) |
| AU (1) | AU2019353367A1 (https=) |
| BR (1) | BR112021005465A2 (https=) |
| CA (1) | CA3107423A1 (https=) |
| IL (1) | IL281929A (https=) |
| MX (1) | MX2021003861A (https=) |
| PH (1) | PH12021500023A1 (https=) |
| SG (1) | SG11202103143UA (https=) |
| TW (1) | TW202028459A (https=) |
| WO (1) | WO2020071365A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220148235A (ko) * | 2020-02-28 | 2022-11-04 | 젠자임 코포레이션 | 최적화된 약물 접합을 위한 변형된 결합 폴리펩티드 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005302083A1 (en) * | 2004-11-04 | 2006-05-11 | Fibron Limited | Treatment of B-cell malignancies |
| CN101965366B (zh) * | 2007-12-26 | 2016-04-27 | 生物测试股份公司 | 靶向cd138的免疫缀合物及其应用 |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| CA2855566A1 (en) * | 2011-12-02 | 2013-06-06 | Ibc Pharmaceuticals, Inc. | Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| KR20140100571A (ko) * | 2011-12-08 | 2014-08-14 | 바이오테스트 아게 | Ｃｄ１３８을 타겟팅하는 면역접합체의 용도 |
| US10633451B2 (en) * | 2012-02-03 | 2020-04-28 | Hoffmann-La Roche Inc. | Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine |
| HK1211208A1 (zh) * | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| US9803021B2 (en) * | 2012-12-07 | 2017-10-31 | The Regents Of The University Of California | CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| CA2942546C (en) * | 2014-03-17 | 2022-11-22 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| RU2611685C2 (ru) * | 2015-07-20 | 2017-02-28 | Илья Владимирович Духовлинов | Гуманизированное моноклональное антитело, специфичное к синдекану-1 |
| KR102642385B1 (ko) * | 2017-02-06 | 2024-03-04 | 오리오니스 바이오사이언시스 엔브이 | 표적화된 키메라 단백질 및 이의 용도 |
| US10722589B2 (en) * | 2017-04-03 | 2020-07-28 | Covagen Ag | FGFR3 binding molecules |
| WO2018199176A1 (en) * | 2017-04-26 | 2018-11-01 | Mitsubishi Tanabe Pharma Corporation | Syndecan-1 (cd138) binding agents and uses thereof |
| JP2021165268A (ja) * | 2020-04-07 | 2021-10-14 | 田辺三菱製薬株式会社 | シンデカン−１および線維芽細胞増殖因子受容体を標的とする二重特異性結合物質を含む医薬組成物 |
-
2019
- 2019-10-01 US US17/282,368 patent/US20220249679A1/en not_active Abandoned
- 2019-10-01 TW TW108135510A patent/TW202028459A/zh unknown
- 2019-10-01 MX MX2021003861A patent/MX2021003861A/es unknown
- 2019-10-01 KR KR1020217011453A patent/KR20210070307A/ko not_active Withdrawn
- 2019-10-01 JP JP2021518202A patent/JP2022514148A/ja not_active Withdrawn
- 2019-10-01 AU AU2019353367A patent/AU2019353367A1/en not_active Abandoned
- 2019-10-01 EP EP19869146.1A patent/EP3861117A4/en not_active Withdrawn
- 2019-10-01 PH PH1/2021/500023A patent/PH12021500023A1/en unknown
- 2019-10-01 BR BR112021005465-0A patent/BR112021005465A2/pt not_active IP Right Cessation
- 2019-10-01 CA CA3107423A patent/CA3107423A1/en active Pending
- 2019-10-01 WO PCT/JP2019/038750 patent/WO2020071365A1/en not_active Ceased
- 2019-10-01 CN CN201980064967.7A patent/CN113039271A/zh active Pending
- 2019-10-01 AR ARP190102778A patent/AR116563A1/es not_active Application Discontinuation
- 2019-10-01 SG SG11202103143UA patent/SG11202103143UA/en unknown
-
2021
- 2021-03-31 IL IL281929A patent/IL281929A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6908722B2 (ja) | 抗ｐｄ−１抗体及びその使用 | |
| RU2743590C2 (ru) | Молекулы со специфичностью в отношении cd79 и cd22 | |
| JP7161400B2 (ja) | Ｃｄ２２に結合する抗体分子 | |
| EP2545076B1 (en) | Biological products: humanised agonistic anti-pd-1 antibodies | |
| JP2024125370A (ja) | クローディン１８．２結合部分およびその利用 | |
| CN102421802B (zh) | 人源化的axl抗体 | |
| AU2018295119B2 (en) | Multi-specific antibodies and methods of making and using thereof | |
| JP2024056687A5 (https=) | ||
| JP6998857B2 (ja) | Ｃｄ７９に結合する抗体分子 | |
| JP2024167313A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP2020504723A5 (https=) | ||
| JP2011046732A5 (https=) | ||
| JP2016503067A5 (https=) | ||
| JP2009225799A5 (https=) | ||
| JP2024501539A5 (https=) | ||
| JP2018093875A5 (https=) | ||
| WO2019196309A1 (zh) | 抗pd-l1抗体及其用途 | |
| JP2021520195A5 (https=) | ||
| JP2021519319A5 (https=) | ||
| JP2023509214A5 (https=) | ||
| KR102567489B1 (ko) | 세포 연계 결합 분자 | |
| CN113574069A (zh) | 抗pd-l1抗体及其用途 | |
| JP2023509215A5 (https=) | ||
| JP2023531230A5 (https=) |